Tags » Antigen

Inside the Blood Factory That Keeps Track of the World's Rare Donors

Rare blood has been covered in a previous post.

Photographer Greg White recently got a tour of the NHS Blood & Transplant’s Filton Blood Center while on assignment for the science publication Mosaic.

137 more words
Today I Learned

From HIV to cancer, Interleukin 37 (IL-37) regulates the immune system.

A University of Colorado Cancer Center study describes the activity of a recently discovered communication molecule of the body’s immune system, Interleukin 37 or IL-37. It has been known to limit inflammation and the current study reports its activity in the adaptive immune system, IL-37 inhibits the ability of the immune system to recognize and target new antigens. 451 more words


Researchers to test whether Ebola survivors' blood can provide new treatment.

The University of Liverpool is part of an international research team that will assess whether the blood or plasma of Ebola survivors can be used to treat Ebola patients in West Africa.  308 more words


The Appendix: Revisited

Antibody engineering and discovering new ways of treating diseases will never be obsolete as long as viruses and other harmful microorganisms continue to thrive and evolve. 438 more words


Chimeric antigen receptor T-cell (CART) therapy: current data, future potential

An article in today’s issue of the New England Journal of Medicine reports data from a Phase II trial of CART therapy in the treatment of patients with acute lymphoblastic leukemia or ALL (an aggressive and difficult to treat form of cancer). 261 more words

Supersensitive nanodevice can detect extremely early cancers

October 5, 2014

Extremely early detection of cancers and other diseases is on the horizon with a supersensitive nanodevice being developed at The University of Alabama in Huntsville (UAH) in collaboration with The Joint School of Nanoscience and Nanoengineering (JSNN) in Greensboro, NC.

880 more words